ARTICLE | Financial News
Ark Therapeutics financial update
February 25, 2013 8:00 AM UTC
The Wellcome Trust (London, U.K.) sold 7.7 million Ark Therapeutics common shares representing less than a 3% stake. The shares are valued at £56,546 ($87,629) based on Ark's close of 0.73p on Feb. 20...